Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 545541 - 545560 out of 553697 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EX01) sunitinib (adm: O) | SUTENT 25MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors;Carcinoma, Renal Cell;Neuroendocrine Tumors | PfizerInc. |
| USA | (L01EX01) sunitinib (adm: O) | SUTENT 25MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors;Carcinoma, Renal Cell;Neuroendocrine Tumors | PfizerInc. |
| USA | (L01EX01) sunitinib (adm: O) | SUTENT 37.5MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors;Carcinoma, Renal Cell;Neuroendocrine Tumors | PfizerInc. |
| USA | (L01EX01) sunitinib (adm: O) | SUTENT 37.5MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors;Carcinoma, Renal Cell;Neuroendocrine Tumors | PfizerInc. |
| USA | (L01EX01) sunitinib (adm: O) | SUTENT 50MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors;Carcinoma, Renal Cell;Neuroendocrine Tumors | PfizerInc. |
| USA | (L01EX01) sunitinib (adm: O) | SUTENT 50MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors;Carcinoma, Renal Cell;Neuroendocrine Tumors | PfizerInc. |
| USA | (L01EX03) pazopanib (adm: O) | PAZOPANIB 200MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GoldenStateMedicalSupply,Inc. |
| USA | (L01EX03) pazopanib (adm: O) | VOTRIENT 200MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | NovartisPharmaceuticalsCorporation |
| USA | (L01EX03) pazopanib (adm: O) | VOTRIENT 200MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | NovartisPharmaceuticalsCorporation |
| USA | (L01EX07) cabozantinib (adm: O) | COMETRIQ 60MG CAP | 84 | Ex-factory price without vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | Exelixis,Inc. |
| USA | (L01EX07) cabozantinib (adm: O) | COMETRIQ 60MG CAP | 84 | Ex-factory price without vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | Exelixis,Inc. |
| USA | (L01EX07) cabozantinib (adm: O) | COMETRIQ 100MG CAP | 56 | Ex-factory price without vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | Exelixis,Inc. |
| USA | (L01EX07) cabozantinib (adm: O) | COMETRIQ 100MG CAP | 56 | Ex-factory price without vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | Exelixis,Inc. |
| USA | (L01EX07) cabozantinib (adm: O) | COMETRIQ 140MG CAP | 112 | Ex-factory price without vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | Exelixis,Inc. |
| USA | (L01EX07) cabozantinib (adm: O) | COMETRIQ 140MG CAP | 112 | Ex-factory price without vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | Exelixis,Inc. |
| USA | (L01EX07) cabozantinib (adm: O) | CABOMETYX 20MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Carcinomas, Hepatocellular | Exelixis,Inc. |
| USA | (L01EX07) cabozantinib (adm: O) | CABOMETYX 20MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Carcinomas, Hepatocellular | Exelixis,Inc. |
| USA | (L01EX07) cabozantinib (adm: O) | CABOMETYX 40MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Carcinomas, Hepatocellular | Exelixis,Inc. |
| USA | (L01EX07) cabozantinib (adm: O) | CABOMETYX 40MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Carcinomas, Hepatocellular | Exelixis,Inc. |
| USA | (L01EX07) cabozantinib (adm: O) | CABOMETYX 60MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Carcinomas, Hepatocellular | Exelixis,Inc. |
Pages
